Pr François Ghiringhelli

Specialty

Oncologist, digestive expert

Hospital

Centre Georges-François Leclerc (Dijon)

Latest articles

• Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doublet. (Jul 1, 2025)
• Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial. (Jun 30, 2025)
• UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity. (Jun 20, 2025)
• Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation. (May 20, 2025)
• The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs. (May 1, 2025)